We are live on ! Find out more
TCM

Tygh Capital Management Portfolio holdings

AUM $782M
1-Year Est. Return 39.44%
This Fund
S&P 500
This Quarter Est. Return
+11.63%
1 Year Est. Return
+39.44%
3 Year Est. Return
+251.35%
5 Year Est. Return
+417.76%
10 Year Est. Return
AUM
$591M
AUM Growth
+$64.3M
Cap. Flow
+$14.9M
Cap. Flow %
2.53%
Top 10 Hldgs %
22.58%
Holding
103
New
13
Increased
54
Reduced
20
Closed
16

Sector Composition

Rank Sector Weight
1 Industrials 26.41%
2 Technology 23.5%
3 Healthcare 13.45%
4 Consumer Discretionary 12.83%
5 Financials 5.8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VIAV icon
51
Viavi Solutions
VIAV
$9.12B
$5.47M 0.93%
534,560
+4,113
+0.8% +$40.7K
FORM icon
52
FormFactor
FORM
$8.28B
$5.46M 0.92%
410,666
+245,636
+149% +$3.33M
HOFT icon
53
Hooker Furnishings Corp
HOFT
$150M
$5.37M 0.91%
114,560
-53,855
-32% -$2.21M
OMN
54
DELISTED
OMNOVA Solutions Inc.
OMN
$5.27M 0.89%
506,783
+112,599
+29% +$1.2M
EFOR
55
Everforth Inc
EFOR
$1.17B
$5.21M 0.88%
66,684
-80,424
-55% -$6.58M
OFIX icon
56
Orthofix Medical
OFIX
$477M
$5.12M 0.87%
90,070
-32,735
-27% -$1.86M
PTEN icon
57
Patterson-UTI
PTEN
$3.98B
$5.08M 0.86%
282,299
+110,507
+64% +$2.22M
RGEN icon
58
Repligen
RGEN
$7.96B
$4.93M 0.83%
+104,709
New +$4.31M
FSCT
59
DELISTED
ForeScout Technologies, Inc. Common Stock
FSCT
$4.79M 0.81%
+139,890
New +$4.54M
CZR icon
60
Caesars Entertainment
CZR
$6.06B
$4.69M 0.79%
120,045
+928
+0.8% +$38.4K
TRHC
61
DELISTED
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
$4.66M 0.79%
73,054
+2,707
+4% +$133K
WBS icon
62
Webster Financial
WBS
$12.5B
$4.65M 0.79%
73,052
+560
+0.8% +$34.9K
SPN
63
DELISTED
Superior Energy Services, Inc.
SPN
$4.65M 0.79%
47,745
+539
+1% +$55.3K
EXP icon
64
Eagle Materials
EXP
$6.29B
$4.45M 0.75%
42,434
-20,253
-32% -$2.13M
LEXEA
65
DELISTED
Liberty Expedia Holdings, Inc. Class A Common Stock
LEXEA
$4.43M 0.75%
100,812
+26,997
+37% +$1.13M
EEFT icon
66
Euronet Worldwide
EEFT
$2.72B
$4.38M 0.74%
+52,267
New +$4.23M
ENV
67
DELISTED
ENVESTNET, INC.
ENV
$4.32M 0.73%
+78,651
New +$4.37M
XBI icon
68
State Street SPDR S&P Biotech ETF
XBI
$9.95B
$4.28M 0.72%
44,966
-45,359
-50% -$4.17M
VAC icon
69
Marriott Vacations Worldwide
VAC
$3.35B
$4.12M 0.7%
+36,435
New +$4.5M
OZK icon
70
Bank OZK
OZK
$5.6B
$3.92M 0.66%
87,050
-48,205
-36% -$2.3M
CCS icon
71
Century Communities
CCS
$1.91B
$3.89M 0.66%
123,399
+945
+0.8% +$29K
ATI icon
72
ATI
ATI
$25.6B
$3.68M 0.62%
146,662
+1,124
+0.8% +$30.4K
COLL icon
73
Collegium Pharmaceutical
COLL
$1.15B
$3.56M 0.6%
149,084
+1,379
+0.9% +$33.9K
OSUR icon
74
OraSure Technologies
OSUR
$279M
$3.55M 0.6%
215,652
+1,627
+0.8% +$27.5K
PUMP icon
75
ProPetro Holding
PUMP
$1.36B
$3.43M 0.58%
218,981
+84,400
+63% +$1.45M

Similar funds

Tygh Capital Management's Q2 2018 Portfolio in Review

As of Q2 2018, Tygh Capital Management held 103 positions worth $591M, up 12% from $526M the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Tygh Capital Management's Q2 2018 filing shows 13 new, 54 increased, 20 reduced and 16 closed positions. Its largest new stake was NovoCure: 250,769 shares worth $7.85M. The largest sale was Talend S.A. American Depositary Shares, an estimated $8.34M.

By sector, the portfolio is most concentrated in Industrials at 26% of assets, up from 26% a quarter earlier, followed by Technology and Healthcare.

  • Tygh Capital Management's largest Q2 2018 buy was NovoCure: 250,769 shares worth $7.85M.
  • Tygh Capital Management added most to Mobile Mini Inc in Q2 2018, an estimated $6.1M increase.
  • Tygh Capital Management's biggest Q2 2018 reduction was Amedisys, cutting an estimated $8.33M.
  • Tygh Capital Management fully exited Talend S.A. American Depositary Shares in Q2 2018, selling an estimated $8.34M.
  • Tygh Capital Management's ten largest holdings make up 23% of its $591M portfolio in Q2 2018.
  • Tygh Capital Management opened 13 new positions and closed 16 in Q2 2018.
  • Tygh Capital Management's portfolio value rose 12% quarter-over-quarter to $591M.

Based on Tygh Capital Management's 13F filing for Q2 2018, filed 9 Aug 2018.